Biocare Medical proudly introduces two newly developed HRP-Polymer detection systems, the Mouse-on-Canine HRP-Polymer and Rabbit-on-Canine HRP-Polymer. These polymers are specifically designed to achieve excellent staining quality when using mouse or rabbit primary antibodies on canine tissues. This addition to Biocare’s Promark series expands IHC detection applications to a broader range of animal tissues, resulting in […]
Biocare Medical is proud to present Vina Green Chromogen to the clinical diagnostic and research markets. The advanced formulation of Vina Green provides stable and vivid staining quality. The chromogen is a two-component system that produces a green stain in the presence of horseradish peroxidase. Vina Green is clearly distinguishable from Warp Red and DAB […]
Biocare Medical is proud to announce a licensing agreement with The Henry M Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) for the exclusive world wide sales and distribution rights of the anti-ERG monoclonal antibody (clone 9FY – the CPDR ERG- MAb) for in-vitro diagnostics, prognostics, patient monitoring, and screening by immunohistochemistry. In […]
The newly formulated Warp Red is a fast, sensitive and more stable alternative to conventional Fast Red chromogens. Warp Red features an accelerated chromogenic reaction, three times faster than Vulcan Fast Red (VFR); a 5-7minute incubation with Warp Red results in an equivalent or superior staining as VFR after 20minutes incubation. A sharper and more […]
Biocare Medical is highly honored to accept the “Top of the Class” awards for both Histology and Automated Pathology* for 2010. These awards recognize our commitment to patient care and the highest quality Molecular Pathology and IHC products. Biocare is dedicated to improving patient care by providing products for early and accurate cancer diagnosis and […]
Biocare Medical would like to thank you for making the 36th Annual National Society of Histotechnology in Seattle, Washington the most successful meeting by far! Over 40% more visitors than last year joined us for an interactive learning experience to find out about the latest IHC and Molecular Pathology technologies, techniques, and products. Over steaming […]
Biocare’s Multiplex IHC Tests Biocare introduces the Lung Adeno-2™ and Lung Squamous-2™ Multiplex IHC tests which aid in the critical differentiation of NSCLC squamous cell carcinoma vs. adenocarcinoma(1) with 100% specificity for squamous cell carcinoma and 79% sensitivity for adenocarcinoma. This differentiation is a critical component in therapeutic decisions such as the use of VEGF […]
Biocare Medical, LLC is pleased to announce a sampling program for p63 antibody for clinical and research laboratories. Biocare Medical is currently one of only two companies worldwide with rights to sell p63 antibodies for IVD testing purposes. Both predilute and concentrated antibodies are available. Biocare announced the favorable resolution of a challenge to its […]
Biocare Medical is proud to launch the Decloaking Chamber™ Plus. This next generation Decloaking Chamber is optimized for programmable walk-away use. Moreover, the new and improved Decloaking Chamber Plus provides the most comprehensive quality control package, validating that antigen retrieval has occurred properly prior to IHC and ISH procedures. “The combination of complete walk-away and […]
Inc. magazine has ranked Biocare Medical No. 2984 on the 2009 Inc. 5000 list of the fastest-growing private companies in the nation. The company’s sales growth was 93.1% from 2005-2008. “We are thrilled to have achieved this prestigious recognition”, said Roy Paxton Yih, co-founder and CEO of Biocare Medical. “It is exciting to see that […]